Can your nose change your cannabis high? Our conversation with cannabis researcher and patient advocate Gil Luxemburg continues in Part 2. Gil's journey involves helping people all over the world get access to medicinal cannabis, but in a surprising turn, he also challenges what we think we know about terpenes, THC, and the entourage effect. Could smell, memory, and expectations explain some perceived cannabis effects? Gil also shares his remarkable experiences influencing medical cannabis policy in the Czech Republic and researching thousands of cannabis plants in Bulgaria. Join Trevor and Kirk Nyquist as they explore an intriguing, still-unproven hypothesis that could change how we think about cannabis aromas and effects.

How did Israel’s medical cannabis Patient 7 become an advocate and educator? Gil Luxenbourg developed severe Crohn’s disease during his Israeli military service. After conventional treatments failed, he received the extraordinary suggestion from a military gastroenterologist: try cannabis. In Part 1, Gil explains his journey to becoming one of Israel’s first licensed medical cannabis patients, helping establish the Israel Medical Cannabis Association, and educating patients and healthcare professionals about safer cannabis use. He discusses why poor dosing and bad first experiences caused many patients to quit—and shares a powerful warning about why patients should always tell their healthcare team about cannabis use. Listen now for a remarkable story about medical cannabis, patient advocacy, education, stigma, and the early evolution of Israel’s cannabis system.